That is essential, due to the fact that the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work. In other words, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (the legacy report predictions). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're created to do. This was a breakthrough almost nobody observed. However it's going to have profound ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of financial investment opportunities in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (melania trump). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe significantly before going higher - jeff brown genetic sequencing stock. I have actually been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. But that's not the huge question any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. democratic republic. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous great private companies on the brink of hitting the public markets And I have actually been working on a new method for you to invest even before these business go public.
This chance has actually been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Journal. Regular Journal readers understand that tech isn't our typical beat (future report). And when it pertains to tech investing, we leave it to the experts. Luckily, we have a number of such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (jeff brown genetic sequencer stock). In truth, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big image and predict what's just around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing rapid development and producing amazing opportunities for investors. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. the legacy report predictions. However in spite of what lots of readers might believe, this is a trend that's just starting. Even though the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown genome sequencing stock). Losing two months of production and sales truly affects how lots of 5G devices are offered in the calendar year. When you think about all of that, selling 250 million units is exceptional. More importantly, the delays triggered by the pandemic created a ton of bottled-up need. And that need is now going to be pressed into 2021. In reality, I anticipate that more than 500 million 5G devices will be shipped in 2021 - brownstone research stock. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I've explained its three various phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Phase Three, 5G services start to be offered (jeff brown investment prediction). That's when we begin to see applications working on 5G networks. Think about things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summer season. This starts something of a virtuous cycle: The majority of people do not actually appreciate the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment chances going forward will be huge. Stepping far from 5G, the next essential innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR utilizes a similar concept but with our genetic code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were really only 3 companies running in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This entire market is effectively a greenfield opportunity.
There's space for lots of companies to exist in this space. jeff brown genetic sequencing stock. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That's essential since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're created to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced using this technology. This was one of those breakthroughs that almost no one discovered. However it's going to have profound implications for curing illness. And, of course, there will be plenty of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe substantially prior to going greater. I have actually been covering bitcoin for a long time now. Among the very first research study reports I ever published was on bitcoin - brownstone research. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. However at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff brown investor prediction. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date as of February 2021, however we might not separately validate this claim. Given Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to select winning innovation stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an outstanding viewpoint on the marketplace. He's always on the hunt for new opportunities, and he shares much of his finest choices in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully anticipated a few of the most significant economic occasions of the past 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it right each time, but Jeff Brown's accurate forecasts have actually earned him legions of devoted followers. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a prominent monetary research study publisher. Brownstone Research uses numerous research study services with a wide array of specializations - jeff brown 2020 predictions.
The company is also associated with Bonner & Partners, another well-respected research publisher - melania trump. On its website, Brownstone says its objective is to offer retail investors with professional-grade research: "For too long, the best investment research has not been available to individual investors. It has been generally booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. melania trump. The mission of Brownstone Research is to make that sort of proprietary research study readily available to any financiers looking to get an edge in the marketplaces. The goal is easy to provide special and profitable investment research discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise functions as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of consistent success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout many of America. If you know even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. black sea. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown believes S.A.V. jeff brown prediction for 2021. might be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding two advanced innovations: artificial intelligence and electrical vehicles. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving vehicles ever. It's absolutely nothing except the automotive market's Holy Grail. As you know, electrical lorries and self-driving cars and truck stocks have actually been big this year, but the Wall Street device has actually been huge on buzz without much tangible outcome. In spite of an extreme boost in competition over the past few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that connects all of it together. S.A.V. means Shared Autonomous Car, and it could be the future of transportation. Essentially, this technology would permit you to lease your car as a self-governing, self-driving taxi when you're not using it. You merely leave the vehicle and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large portion of the revenues. It sounds ridiculous, however it could be closed than you think.